Blood level of cyclosporin [correction of cyclospolin] during LDL-apheresis in nephrotic syndrome patients

J Clin Apher. 1999;14(4):193-4. doi: 10.1002/(sici)1098-1101(1999)14:4<193::aid-jca9>3.0.co;2-g.
No abstract available

MeSH terms

  • Adolescent
  • Adsorption
  • Blood Component Removal*
  • Child
  • Cyclosporine / blood*
  • Cyclosporine / chemistry
  • Cyclosporine / pharmacokinetics
  • Female
  • Glomerulosclerosis, Focal Segmental / complications
  • Humans
  • Immunosuppressive Agents / blood*
  • Immunosuppressive Agents / pharmacokinetics
  • Lipoproteins, LDL / chemistry*
  • Nephrotic Syndrome / blood*
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / etiology
  • Nephrotic Syndrome / therapy

Substances

  • Immunosuppressive Agents
  • Lipoproteins, LDL
  • Cyclosporine